Author:
Krone W.,Greten H.,Richter W. O.,Schwandt P.,Koschinsky T.,Brix L.,Bünting C.,Gries F. A.,Wicklmayr M.,Dietze G.,Brunnbauer H.,Mehnert H.,Burkard W.,Heckers H.,Platt D.,Kostner G. M.,Augustin J.,Beedgen B.,Spohr U.,Schettler G.,Wolfram G.,Adam O.,Eckart J.,Zöllner N.,Weisweiler P.,Janetschek P.,Tschöpe W.,Ritz E.,Manz F.,Möhring K.,Knebel L.,Banholzer P.,Gröbner W.,Reiter S.,Doss M.,von Tiepermann R.,Verspohl F.,Becker U.,Pflüger K.-H.,Kaffarnik H.,Arab L.,Schellenberg B.,Schlierf G.,Löffler W.,Seidl O.,Keller C.
Reference100 articles.
1. Kannel WB, Castelli WB, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins and the risk of coronary heart disease. Ann Intern Med 74: 1–12
2. Goldstein JL, Brown MS (1976) The LDL pathway in human fibroblasts: A receptor-mediated mechanism for the regulation of cholesterol metabolism. Curr Top Cell Regul 11: 147–181
3. Krone W, Betteridge DJ, Galton DJ (1979) Mechanism of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by low density lipoprotein in human lymphocytes. Eur J Clin Invest 9: 405–410
4. Williams TL, Synderman R, Lefkowitz RJ (1976) Identification of ß-adrenergic receptors in human lymphocytes by (—)-(3H) alprenolol binding. J Clin Invest 57: 149–155
5. Fredholm BB (1978) Local regulation of lipolysis in adipose tissue by fatty acids, prostaglandins and adenosine. Med Biol 56: 249–261